TEMAZEPAM OPTIONS

Coadministration with CYP3A4 substrates, specifically These having a slender therapeutic index, may end up in diminished concentrations and loss of efficacy. If not able to steer clear of coadministration, observe CYP3A4 substrate ranges and regulate dose as necessary.If unavoidable, keep track of people for loss of efficacy Except if not advisable